Quick Answer
FENNEC PHARMACEUTICALS INC. reported Common Stock Shares Outstanding of 34.16 million shares for the year ending 2025.
- FENNEC PHARMACEUTICALS INC. showed an increase of +24.1% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from FENNEC PHARMACEUTICALS INC.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), FENNEC PHARMACEUTICALS INC.'s Common Stock Shares Outstanding has grown by 67.0%.
- Historical annual values: Fiscal year 2025: 34.16 million shares | Fiscal year 2024: 27.53 million shares | Fiscal year 2023: 27.03 million shares | Fiscal year 2022: 26.36 million shares | Fiscal year 2021: 26.01 million shares | Fiscal year 2020: 26.00 million shares | Fiscal year 2019: 19.90 million shares | Fiscal year 2018: 19.90 million shares | Fiscal year 2017: 18.41 million shares | Fiscal year 2016: 13.64 million shares | Fiscal year 2015: 10.94 million shares | Fiscal year 2014: 10.59 million shares | Fiscal year 2013: 9.72 million shares | Fiscal year 2012: 25.16 million shares | Fiscal year 2011: 25,158 shares | Fiscal year 2010: 20.46 million shares.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: